indagatio clinical limited Company Information
Company Number
09107028
Website
-Registered Address
1 barrington road, orwell, royston, hertfordshire, SG8 5QP
Industry
Other research and experimental development on natural sciences and engineering
Telephone
01223208219
Next Accounts Due
October 2024
Group Structure
View All
Directors
Lisa Butler10 Years
Shareholders
lisa hayley butler 100%
indagatio clinical limited Estimated Valuation
Pomanda estimates the enterprise value of INDAGATIO CLINICAL LIMITED at £25.8k based on a Turnover of £29.1k and 0.89x industry multiple (adjusted for size and gross margin).
indagatio clinical limited Estimated Valuation
Pomanda estimates the enterprise value of INDAGATIO CLINICAL LIMITED at £0 based on an EBITDA of £-7.6k and a 3.91x industry multiple (adjusted for size and gross margin).
indagatio clinical limited Estimated Valuation
Pomanda estimates the enterprise value of INDAGATIO CLINICAL LIMITED at £1.6k based on Net Assets of £645 and 2.55x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Indagatio Clinical Limited Overview
Indagatio Clinical Limited is a dissolved company that was located in royston, SG8 5QP with a Companies House number of 09107028. It operated in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in June 2014, it's largest shareholder was lisa hayley butler with a 100% stake. The last turnover for Indagatio Clinical Limited was estimated at £29.1k.
Upgrade for unlimited company reports & a free credit check
Indagatio Clinical Limited Health Check
Pomanda's financial health check has awarded Indagatio Clinical Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 8 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
8 Weak
Size
annual sales of £29.1k, make it smaller than the average company (£3.1m)
- Indagatio Clinical Limited
£3.1m - Industry AVG
Growth
3 year (CAGR) sales growth of -24%, show it is growing at a slower rate (2.8%)
- Indagatio Clinical Limited
2.8% - Industry AVG
Production
with a gross margin of 26.3%, this company has a higher cost of product (47.1%)
- Indagatio Clinical Limited
47.1% - Industry AVG
Profitability
an operating margin of -26.1% make it less profitable than the average company (3.6%)
- Indagatio Clinical Limited
3.6% - Industry AVG
Employees
with 1 employees, this is below the industry average (41)
1 - Indagatio Clinical Limited
41 - Industry AVG
Pay Structure
on an average salary of £57.7k, the company has an equivalent pay structure (£57.7k)
- Indagatio Clinical Limited
£57.7k - Industry AVG
Efficiency
resulting in sales per employee of £29.1k, this is less efficient (£100.5k)
- Indagatio Clinical Limited
£100.5k - Industry AVG
Debtor Days
it gets paid by customers after 23 days, this is earlier than average (51 days)
- Indagatio Clinical Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 10 days, this is quicker than average (50 days)
- Indagatio Clinical Limited
50 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Indagatio Clinical Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Indagatio Clinical Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 65.6%, this is a higher level of debt than the average (49.3%)
65.6% - Indagatio Clinical Limited
49.3% - Industry AVG
INDAGATIO CLINICAL LIMITED financials
Indagatio Clinical Limited's latest turnover from November 2021 is estimated at £29.1 thousand and the company has net assets of £645. According to their latest financial statements, Indagatio Clinical Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | |
---|---|---|---|---|---|---|---|
Turnover | |||||||
Other Income Or Grants | |||||||
Cost Of Sales | |||||||
Gross Profit | |||||||
Admin Expenses | |||||||
Operating Profit | |||||||
Interest Payable | |||||||
Interest Receivable | |||||||
Pre-Tax Profit | |||||||
Tax | |||||||
Profit After Tax | |||||||
Dividends Paid | |||||||
Retained Profit | |||||||
Employee Costs | |||||||
Number Of Employees | 1 | 1 | 1 | 1 | 1 | ||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | |
---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 1,479 | 1,499 | 966 | 1,756 | 1,845 | 488 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 1,479 | 1,499 | 966 | 1,756 | 1,845 | 488 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 1,873 | 8,615 | 14,946 | 22,269 | 34,678 | 14,249 | 9,175 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 0 | 0 | 0 | 0 | 0 | 24,624 | 41,096 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,873 | 8,615 | 14,946 | 22,269 | 34,678 | 38,873 | 50,271 |
total assets | 1,873 | 10,094 | 16,445 | 23,235 | 36,434 | 40,718 | 50,759 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 618 | 1,147 | 4,664 | 8,200 | 12,123 | 15,064 | 17,729 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 618 | 1,147 | 4,664 | 8,200 | 12,123 | 15,064 | 17,729 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 610 | 718 | 832 | 603 | 6,403 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 610 | 718 | 832 | 603 | 6,403 | 0 | 0 |
total liabilities | 1,228 | 1,865 | 5,496 | 8,803 | 18,526 | 15,064 | 17,729 |
net assets | 645 | 8,229 | 10,949 | 14,432 | 17,908 | 25,654 | 33,030 |
total shareholders funds | 645 | 8,229 | 10,949 | 14,432 | 17,908 | 25,654 | 33,030 |
Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | |
---|---|---|---|---|---|---|---|
Operating Activities | |||||||
Operating Profit | |||||||
Depreciation | 452 | 162 | |||||
Amortisation | 0 | 0 | |||||
Tax | |||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -6,742 | -6,331 | -7,323 | -12,409 | 20,429 | 5,074 | 9,175 |
Creditors | -529 | -3,517 | -3,536 | -3,923 | -2,941 | -2,665 | 17,729 |
Accruals and Deferred Income | -108 | -114 | 229 | -5,800 | 6,403 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | |||||||
Investing Activities | |||||||
capital expenditure | |||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | |||||||
Financing Activities | |||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||
interest | |||||||
cash flow from financing | |||||||
cash and cash equivalents | |||||||
cash | 0 | 0 | 0 | 0 | -24,624 | -16,472 | 41,096 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 0 | 0 | 0 | 0 | -24,624 | -16,472 | 41,096 |
indagatio clinical limited Credit Report and Business Information
Indagatio Clinical Limited Competitor Analysis
Perform a competitor analysis for indagatio clinical limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in SG8 area or any other competitors across 12 key performance metrics.
indagatio clinical limited Ownership
INDAGATIO CLINICAL LIMITED group structure
Indagatio Clinical Limited has no subsidiary companies.
Ultimate parent company
INDAGATIO CLINICAL LIMITED
09107028
indagatio clinical limited directors
Indagatio Clinical Limited currently has 1 director, Dr Lisa Butler serving since Jun 2014.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Lisa Butler | United Kingdom | 54 years | Jun 2014 | - | Director |
P&L
November 2021turnover
29.1k
-29%
operating profit
-7.6k
0%
gross margin
26.4%
-6.12%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2021net assets
645
-0.92%
total assets
1.9k
-0.81%
cash
0
0%
net assets
Total assets minus all liabilities
indagatio clinical limited company details
company number
09107028
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
June 2014
age
10
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
November 2021
previous names
N/A
accountant
ALLAN SMITH ACCOUNTING & TAX LIMITED
auditor
-
address
1 barrington road, orwell, royston, hertfordshire, SG8 5QP
Bank
-
Legal Advisor
-
indagatio clinical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to indagatio clinical limited.
indagatio clinical limited Companies House Filings - See Documents
date | description | view/download |
---|